HMA contributes to NAM perspectives discussion paper ‘Guide for Future Directions for Addiction and OUD Treatment Ecosystem’
April 7, 2021
HMA Managing Directors R. Corey Waller, MD, MS, and Jean Glossa, MD, MBA, along with members of the Prevention, Treatment, and Recovery Working Group of the Action Collaborative on Countering the U.S. Opioid Epidemic, recently authored a new National Academy of Medicine Perspectives discussion paper calling for a long-term sustainable approach to preventing and managing addiction as a chronic disease.
To adequately respond to America’s drug overdose and death epidemic, the paper states the ecosystem in which people with addiction receive treatment must be reimagined and made more robust. The National Academy’s framework best describes the needs of and solutions for the addiction treatment ecosystem using the guidance of ‘the 4 Cs”: capacity, competency, consistency, and compensation.
Authors
R. Corey Waller, MD, MS, Managing Director, HMA Institute on Addiction
Kelly J. Clark, MD, MBA, DFAPA, DFASAM, President, Addiction Crisis Solutions and Immediate Past President, American Society of Addiction Medicine.
Alex Woodruff, MPH, policy analyst, Partnered Evidence-based Policy Resource Center, VA Boston Healthcare System.
Jean Glossa, MD, MBA, Managing Director, Delivery System, HMA
Andrey Ostrovsky, MD, Managing Partner, Social Innovation Ventures